Phair Pricing Act of 2019
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Phair Pricing Act of 2019
This bill requires that certain negotiated prices for covered drugs under the Medicare prescription drug benefit be disclosed at the point-of-sale.
Specifically, negotiated prices offered under a prescription drug plan (PDP) must be disclosed at the point-of-sale; the disclosed price must include specified adjustments, payments, and fees that are negotiated with the pharmacy (e.g., dispensing fees) by the PDP sponsor or pharmacy benefit manager.
Additionally, the Centers for Medicare & Medicaid Services must establish certain quality measures for PDP sponsors to use when determining incentive payments and adjustments (e.g., performance payments) to pharmacies.
Read twice and referred to the Committee on Finance.
- Introduced in Senate Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). S. 640: Phair Pricing Act of 2019. 116th Congress. Open America. https://openamerica.io/bill/116-S-640/
"S. 640: Phair Pricing Act of 2019." 116th Congress, 2026, Open America, https://openamerica.io/bill/116-S-640/.
S. 640, 116th Cong. (2026), https://openamerica.io/bill/116-S-640/.
[S. 640: Phair Pricing Act of 2019](https://openamerica.io/bill/116-S-640/)